ID NOW™ COVID-19 Assay
The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.
Availability: Commercially Available
+1 224 667 6100
100 Abbott Park Road
Abbott Park, Ill. 60064
USA
|
|
www.abbott.com/
Manufacturer |
| Abbott Laboratories |
Product Name |
| ID NOW™ COVID-19 Assay |
Detection Category |
| Biological |
Detection Principle |
| Molecular; |
Detection Method |
| Assays;Nucleic Acid Amplification; |
Application |
| Detection;Diagnostics; |
Equipment Type |
| Diagnostic |
Product Synopsis |
| The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene. |
Availability |
| Commercially Available |
Technology Readiness Level (TRL) |
| 9 |
Market Entry Date |
| April 2020 |
User Feedback Sources |
| Indifferent/No user feedback |
No Information Is Available |
Transportability |
| Benchtop/Fixed; Small Footprint |
Other Biological Targets |
| SARS-CoV-2 |
Sample Introduction |
| Liquid; |
Response Time (Sample Application To Output) |
| <15 minutes |
Training Required |
| <1 day training |